跳至主要内容
临床试验/NL-OMON47264
NL-OMON47264已完成3 期

Duloxetine for chronic osteoarthritis pain; an important alternative? - DUO-trial

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 224 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
224

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) having hip or knee OA based on the clinical ACR criteria, and 2) having chronic pain (most days of the last three months) in hip or knee, and 3) either: (i) a contra-indication for NSAIDs; (ii) adverse reactions of NSAIDs; or (iii) insufficient benefit of NSAIDs.

排除标准

  • 1) on waiting list for hip/knee replacement, and 2) use of antidepressants or neuropathic pain medication 3) contra-indication of duloxetine (use of Monoamine Oxidase Inhibitors, having uncontrolled narrow-angle glaucoma, in combination with (other) central nervous system acting drugs, in combination with thioridazine, hypersensitivity to duloxetine, disturbed liverfunction, renal insufficiency (creatinine clearance < 30ml/min), usage of strong CYP1A2-inhibitors and CYP2D6-inhibitors and substrates).

研究者

相似试验